In vivo engineering of immunosuppressive T cells to treat ocular autoimmune diseases. Wang D, Ling J, Liang J, Li J, et al. Exp Eye Res 2026 Apr 28:111041. doi: 10.1016/j.exer.2026.111041.

Read + Share

Amedeo Smart

Independent Medical Education

Wang D, Ling J, Liang J, Li J, et al. In vivo engineering of immunosuppressive T cells to treat ocular autoimmune diseases. Exp Eye Res 2026 Apr 28:111041. doi: 10.1016/j.exer.2026.111041.
PMID: 42061599